BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19499584)

  • 1. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia.
    Caron JE; Krull KR; Hockenberry M; Jain N; Kaemingk K; Moore IM
    Pediatr Blood Cancer; 2009 Oct; 53(4):551-6. PubMed ID: 19499584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
    Krull KR; Hockenberry MJ; Miketova P; Carey M; Moore IM
    Leuk Lymphoma; 2013 Mar; 54(3):535-40. PubMed ID: 22856670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and neurobehavioral problems in pediatric acute lymphoblastic leukemia patients undergoing chemotherapy.
    Stenzel SL; Krull KR; Hockenberry M; Jain N; Kaemingk K; Miketova P; Moore IM
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):113-8. PubMed ID: 20098337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
    Cheung YT; Khan RB; Liu W; Brinkman TM; Edelmann MN; Reddick WE; Pei D; Panoskaltsis-Mortari A; Srivastava D; Cheng C; Robison LL; Hudson MM; Pui CH; Krull KR
    JAMA Oncol; 2018 Jul; 4(7):e180089. PubMed ID: 29596541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
    Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
    Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
    Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM
    J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Activity Associated With Attention Deficits Following Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
    Fellah S; Cheung YT; Scoggins MA; Zou P; Sabin ND; Pui CH; Robison LL; Hudson MM; Ogg RJ; Krull KR
    J Natl Cancer Inst; 2019 Feb; 111(2):201-209. PubMed ID: 29790971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative Stress, Motor Abilities, and Behavioral Adjustment in Children Treated for Acute Lymphoblastic Leukemia.
    Hockenberry MJ; Krull KR; Insel KC; Harris LL; Gundy PM; Adkins KB; Pasvogel AE; Taylor OA; Koerner KM; Montgomery DW; Ross AK; Hill A; Moore IM
    Oncol Nurs Forum; 2015 Sep; 42(5):542-9. PubMed ID: 26302283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity: A Case Series.
    Taylor OA; Hockenberry MJ; McCarthy K; Gundy P; Montgomery D; Ross A; Scheurer ME; Moore IM
    J Pediatr Oncol Nurs; 2015; 32(5):320-5. PubMed ID: 25637187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau.
    Elens I; Deprez S; Danckaerts M; Bijttebier P; Labarque V; Uyttebroeck A; Van Gool S; D'Hooge R; Lemiere J
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
    Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
    PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
    Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.